S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
S&P 500   3,120.18 (-0.06%)
DOW   27,934.02 (-0.36%)
QQQ   203.37 (+0.15%)
AAPL   266.29 (-0.30%)
FB   199.32 (+0.97%)
MSFT   150.39 (+0.03%)
GOOGL   1,312.59 (-0.55%)
AMZN   1,752.79 (+0.01%)
CGC   15.32 (+7.74%)
NVDA   207.99 (-2.02%)
MU   46.58 (-2.59%)
BABA   185.25 (+0.35%)
GE   11.50 (+0.52%)
TSLA   359.52 (+2.72%)
T   38.00 (-3.80%)
AMD   41.29 (+3.54%)
ACB   2.34 (+2.63%)
F   8.90 (-0.56%)
PRI   131.64 (+0.41%)
NFLX   302.60 (+0.01%)
BAC   32.94 (-0.06%)
GILD   65.00 (+1.10%)
DIS   148.38 (+0.49%)
Log in

Waters Stock Price, Forecast & Analysis (NYSE:WAT)

$219.72
+3.38 (+1.56 %)
(As of 11/19/2019 04:00 PM ET)
Today's Range
$216.04
Now: $219.72
$220.53
50-Day Range
$208.00
MA: $216.33
$227.00
52-Week Range
$173.41
Now: $219.72
$255.21
Volume285,723 shs
Average Volume589,414 shs
Market Capitalization$14.16 billion
P/E Ratio26.50
Dividend YieldN/A
Beta1.04
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. Read More…

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
CUSIP94184810
Phone508-478-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.42 billion
Cash Flow$10.04 per share
Book Value$20.69 per share

Profitability

Net Income$593.79 million

Miscellaneous

Employees7,200
Market Cap$14.16 billion
Next Earnings Date1/22/2020 (Estimated)
OptionableOptionable

Receive WAT News and Ratings via Email

Sign-up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter.


Waters (NYSE:WAT) Frequently Asked Questions

What is Waters' stock symbol?

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

How will Waters' stock buyback program work?

Waters declared that its board has authorized a stock buyback program on Tuesday, April 24th 2018, which allows the company to repurchase $3,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy up to 18.2% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's board of directors believes its shares are undervalued.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) released its quarterly earnings data on Tuesday, October, 29th. The medical instruments supplier reported $2.13 EPS for the quarter, hitting the consensus estimate of $2.13. The medical instruments supplier earned $577.28 million during the quarter, compared to analyst estimates of $588.35 million. Waters had a return on equity of 77.73% and a net margin of 23.98%. Waters's revenue for the quarter was down .1% on a year-over-year basis. During the same period in the prior year, the business earned $1.92 EPS. View Waters' Earnings History.

When is Waters' next earnings date?

Waters is scheduled to release their next quarterly earnings announcement on Wednesday, January 22nd 2020. View Earnings Estimates for Waters.

What guidance has Waters issued on next quarter's earnings?

Waters updated its fourth quarter earnings guidance on Tuesday, October, 29th. The company provided earnings per share guidance of $2.95-3.05 for the period, compared to the Thomson Reuters consensus estimate of $3.23. The company issued revenue guidance of $715-729 million, compared to the consensus revenue estimate of $735.22 million.

What price target have analysts set for WAT?

11 brokers have issued 1-year price objectives for Waters' shares. Their forecasts range from $177.00 to $260.00. On average, they expect Waters' share price to reach $208.73 in the next twelve months. This suggests that the stock has a possible downside of 5.0%. View Analyst Price Targets for Waters.

What is the consensus analysts' recommendation for Waters?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 sell ratings, 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Waters.

Has Waters been receiving favorable news coverage?

News headlines about WAT stock have trended very negative on Tuesday, InfoTrie reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Waters earned a media sentiment score of -3.4 on InfoTrie's scale. They also assigned news headlines about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Waters.

Who are some of Waters' key competitors?

What other stocks do shareholders of Waters own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Home Depot (HD), Alibaba Group (BABA), Honeywell International (HON), CVS Health (CVS), Raytheon (RTN), Cisco Systems (CSCO), QUALCOMM (QCOM), Procter & Gamble (PG) and Verizon Communications (VZ).

Who are Waters' key executives?

Waters' management team includes the folowing people:
  • Christopher James O'Connell, Chairman & CEO (Age 52)
  • Mr. Christopher James O'Connell, Chairman & CEO (Age 52)
  • Ms. Sherry L. Buck, Sr. VP & CFO (Age 55)
  • Mr. Francis S. Kim, Sr. VP of Global Operations (Age 52)
  • Mr. Robert G. Carson, Sr. VP of Corp. Devel. & Interim Pres of TA Bus. (Age 45)

Who are Waters' major shareholders?

Waters' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Massachusetts Financial Services Co. MA (8.65%), Marathon Asset Management LLP (0.69%), Beck Mack & Oliver LLC (0.58%), Newport Trust Co (0.45%), Boston Trust Walden Corp (0.43%) and Sumitomo Mitsui Trust Holdings Inc. (0.43%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly, Thomas P Salice and William J Miller. View Institutional Ownership Trends for Waters.

Which institutional investors are selling Waters stock?

WAT stock was sold by a variety of institutional investors in the last quarter, including State of Tennessee Treasury Department, First Trust Advisors LP, Robecosam AG, Fenimore Asset Management Inc., Marathon Asset Management LLP, Harvey Investment Co. LLC, Triodos Investment Management BV and Beck Mack & Oliver LLC. Company insiders that have sold Waters company stock in the last year include Elizabeth B Rae, Ian King, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Insider Buying and Selling for Waters.

Which institutional investors are buying Waters stock?

WAT stock was purchased by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Anchor Capital Advisors LLC, State of New Jersey Common Pension Fund D, Assenagon Asset Management S.A., California Public Employees Retirement System, Ferguson Wellman Capital Management Inc., Boston Trust Walden Corp and First Quadrant L P CA. View Insider Buying and Selling for Waters.

How do I buy shares of Waters?

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Waters' stock price today?

One share of WAT stock can currently be purchased for approximately $219.72.

How big of a company is Waters?

Waters has a market capitalization of $14.16 billion and generates $2.42 billion in revenue each year. The medical instruments supplier earns $593.79 million in net income (profit) each year or $8.29 on an earnings per share basis. Waters employs 7,200 workers across the globe.View Additional Information About Waters.

What is Waters' official website?

The official website for Waters is http://www.waters.com/.

How can I contact Waters?

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]


MarketBeat Community Rating for Waters (NYSE WAT)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  391 (Vote Outperform)
Underperform Votes:  529 (Vote Underperform)
Total Votes:  920
MarketBeat's community ratings are surveys of what our community members think about Waters and other stocks. Vote "Outperform" if you believe WAT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WAT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/19/2019 by MarketBeat.com Staff

Featured Article: Penny Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel